“Neural Killer” Cells: Autologous Cytotoxic Neural Stem Cells for Fighting Glioma
Naresh Mutukula, Yechiel Elkabetz
Index: 10.1016/j.stem.2017.03.019
Full Text: HTML
Abstract
Recently in Science Translational Medicine, Bagó et al. reported an advance in treating glioblastoma using tumor-homing cytotoxic induced neural stem cells (h-iNSCTE). This approach circumvents problems associated with immune rejection and minimizes the bench-to-clinic time window critical for these patients.
Latest Articles:
2017-07-13
[10.1016/j.stem.2017.06.004]
Lineage Tracing: Papers and Progress
2017-07-06
[10.1016/j.stem.2017.06.015]
Intestinal Enteroendocrine Lineage Cells Possess Homeostatic and Injury-Inducible Stem Cell Activity
2017-07-06
[10.1016/j.stem.2017.06.014]
Direct Neuronal Reprogramming: Achievements, Hurdles, and New Roads to Success
2017-07-06
[10.1016/j.stem.2017.06.011]
Making HSCs on Demand: Looking Ahead
2017-07-06
[10.1016/j.stem.2017.06.010]